Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

512
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
512
The Micturition Reflex01:26

The Micturition Reflex

368
Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
368
The Parasympathetic Nervous System01:14

The Parasympathetic Nervous System

106.1K
Overview
106.1K
Autonomic Nervous System01:22

Autonomic Nervous System

8.1K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
8.1K
Autonomic Nervous System: Overview01:26

Autonomic Nervous System: Overview

3.7K
The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...
3.7K
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

941
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
941

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Noninvasive NESA Microcurrent Neuromodulation for Refractory Overactive Bladder in Women: A Triple-Blind, Randomized, Sham-Controlled Pilot Trial.

Medicina (Kaunas, Lithuania)·2026
Same author

Direct Vision Internal Urethrotomy in the Management of Bulbar Urethral Strictures: Long-Term Follow-Up and Factors Predicting Treatment Failure.

Urologia internationalis·2025
Same author

Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology.

European urology·2024
Same author

Recurrent Bacteriuria as a Prognosis Marker in the Adjuvant Treatment of Non-Muscle Invasive Bladder Cancer.

Clinical genitourinary cancer·2024
Same author

Can we define the optimal postvoid residual volume at which intermittent catheterization should be recommended, and are there other measures that could guide an intermittent catheterization protocol: ICI-RS 2023.

Neurourology and urodynamics·2023
Same author

Long-Term Functional Outcomes and Quality of Life after Male Transobturator-Retrourethral Sling Surgery.

Urologia internationalis·2023

Related Experiment Video

Updated: May 23, 2025

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.0K

Targeting the Autonomic Nervous System for Treatment of Urinary Incontinence.

Guillermo Conde-Santos1, Barbara Padilla-Fernández2

  • 1Urology Department, Hospital Quironsalud Tenerife, Santa Cruz, Spain; Faculty of Biomedical and Health Sciences, Universidad Europea de Canarias, Santa Cruz, Spain.

European Urology Focus
|March 11, 2025
PubMed
Summary
This summary is machine-generated.

Autonomic nervous system (ANS) imbalance contributes to urge urinary incontinence (UUI). Treatments targeting the ANS show therapeutic potential for restoring bladder function and improving UUI outcomes.

Keywords:
Autonomic nervous systemOveractive BladderUrinary incontinence

More Related Videos

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.2K
A Decentralized Ex Vivo Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling
06:36

A Decentralized Ex Vivo Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling

Published on: November 28, 2019

7.1K

Related Experiment Videos

Last Updated: May 23, 2025

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.0K
Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.2K
A Decentralized Ex Vivo Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling
06:36

A Decentralized Ex Vivo Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling

Published on: November 28, 2019

7.1K

Area of Science:

  • Urology
  • Neuroscience
  • Pharmacology

Background:

  • Urinary incontinence affects millions globally.
  • Autonomic nervous system (ANS) imbalance is increasingly recognized as a cause of urge urinary incontinence (UUI).
  • Targeting sympathetic and parasympathetic pathways offers therapeutic potential for UUI.

Purpose of the Study:

  • To review current pharmacological and neuromodulation strategies targeting the ANS for bladder dysfunction.
  • To highlight the role of ANS balance in managing urge urinary incontinence.
  • To identify future research directions for optimizing UUI treatment.

Main Methods:

  • Mini-review of existing literature on ANS and UUI.
  • Discussion of pharmacological agents affecting the ANS.
  • Analysis of neuromodulation techniques for bladder control.

Main Results:

  • Current research indicates ANS dysfunction is a key factor in UUI.
  • Pharmacological and neuromodulation therapies targeting the ANS can restore bladder function.
  • Optimizing ANS-targeted therapies may improve patient outcomes.

Conclusions:

  • ANS dysfunction is a significant contributor to urge urinary incontinence.
  • Targeted pharmacological and neuromodulation approaches offer promising treatments for UUI.
  • Further research is crucial to refine ANS-based therapies and combination treatments for personalized UUI management.